North America Biosimilars Market Opportunities, Statistics, Size, Share, Competitive Landscape with Forecast to 2028
According to Business Market Insights’ research, the North America Biosimilars Market was valued at US$ 7,115.74 million in 2022 and is expected to reach US$ 47,746.80 million by 2028, registering a CAGR of 37.3% from 2022 to 2028. Increasing prevalence of chronic diseases and cost effectiveness of biosimilar drugs are the critical factors attributed to the North America biosimilars market expansion.
Download Sample PDF Copy: https://www.businessmarketinsights.com/sample/BMIRE00028371
The List of Companies
- Amgen Inc
- Celltrion Inc
- Sanofi SA
- Biocon Ltd
- Coherus BioSciences Inc
- Eli Lilly and Co
- Sandoz AG
- Teva Pharmaceutical Industries Ltd
- Pfizer Inc
- Dr. Reddy's Laboratories Ltd
The global burden of chronic diseases is escalating, driven by several converging factors:
Aging Population: As life expectancy increases, so does the proportion of elderly individuals, who are more susceptible to chronic conditions.
Lifestyle Changes: Urbanization and modern lifestyles often promote sedentary behavior, unhealthy diets, and increased stress, contributing to obesity and related diseases.
Genetic Predisposition: Twin studies have demonstrated a strong genetic component in chronic diseases like cardiovascular disease (CVD), diabetes, obesity, Alzheimer's disease (AD), and depression.
High Prevalence:
The National Council on Aging, Inc. reports that 80% of adults aged 65 and older have at least one chronic condition, with 68% having two or more.
The Centers for Disease Control and Prevention (CDC) found that in 2020, nearly 60% of adults in the US had at least one chronic disease, and 40% had two or more.
Specific examples of the rising prevalence of major chronic diseases include:
Cardiovascular Diseases (CVDs):
CVDs, including atherosclerosis, angina pectoris, and acute myocardial infarction, are the leading cause of death worldwide.
The World Health Organization (WHO) estimates that CVDs account for 17.9 million deaths annually.
Diabetes:
Diabetes is a chronic disease with severe complications such as heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage.
The International Diabetes Federation (IDF) projects that the number of diabetic cases in North America will rise from 46 million in 2017 to 62 million by 2045.
Globally, the IDF reported 425 million people living with diabetes in 2017, with projections indicating a rise to 629 million by 2045, representing an estimated 35% increase.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
Comments
Post a Comment